Fully portable and automated blood sampling system
Making use of the dried blood spot technology in a new unique way
A small revolution in blood sampling
Fluisense has full focus on CE approval of Fluispotter and in order to reach the goal we are happy that is has been possible to strengthen the team with four new employees.
Malene Schrøder takes over the position as CEO. Sten Velschow continues as CTO.
Fluisense has added three strong resources to the team; we are happy to welcome Anita Gundorph, Sanne Larsen and Helle Key Jensen.
Fluisense has been granted patent in Europe. EP 2884895.
Fluisense has been granted patent in Europe. EP 2884896.
Fluisense has been granted 5.8 mio DKK to test Fluispotter in a 3 year project with Rigshospitalet and Herlev Hospital.
Phone: +45 25 94 05 95